R Edelstein

770 total citations
23 papers, 580 citations indexed

About

R Edelstein is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, R Edelstein has authored 23 papers receiving a total of 580 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 4 papers in Surgery. Recurrent topics in R Edelstein's work include Blood transfusion and management (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Diphtheria, Corynebacterium, and Tetanus (2 papers). R Edelstein is often cited by papers focused on Blood transfusion and management (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Diphtheria, Corynebacterium, and Tetanus (2 papers). R Edelstein collaborates with scholars based in France and United States. R Edelstein's co-authors include Lucien Israël, A Depierre, Donald G. McKay, Robert M. Hardaway, A Moulonguet, Pierre Costa, T Billebaud, Jean Fiet, Jean‐Marc Husson and R Dahan and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JNCI Journal of the National Cancer Institute.

In The Last Decade

R Edelstein

23 papers receiving 479 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
R Edelstein 183 149 132 94 90 23 580
J. Jansen 215 1.2× 76 0.5× 137 1.0× 30 0.3× 124 1.4× 18 845
Masaki Kawakami 117 0.6× 115 0.8× 173 1.3× 36 0.4× 74 0.8× 16 604
J E Parrillo 114 0.6× 121 0.8× 170 1.3× 12 0.1× 88 1.0× 26 744
J Hugues 100 0.5× 38 0.3× 183 1.4× 19 0.2× 59 0.7× 36 552
Jeanne A. Lumadue 81 0.4× 103 0.7× 45 0.3× 16 0.2× 153 1.7× 16 567
S. Segal 35 0.2× 45 0.3× 58 0.4× 62 0.7× 92 1.0× 42 497
Øyvind Bruserud 54 0.3× 177 1.2× 192 1.5× 75 0.8× 188 2.1× 39 680
E. Dybkjær 41 0.2× 100 0.7× 84 0.6× 33 0.4× 107 1.2× 42 845
Bradley P. Sullivan 90 0.5× 82 0.6× 245 1.9× 32 0.3× 218 2.4× 29 934
M Kopeć 480 2.6× 52 0.3× 55 0.4× 35 0.4× 125 1.4× 77 1.0k

Countries citing papers authored by R Edelstein

Since Specialization
Citations

This map shows the geographic impact of R Edelstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Edelstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Edelstein more than expected).

Fields of papers citing papers by R Edelstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Edelstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Edelstein. The network helps show where R Edelstein may publish in the future.

Co-authorship network of co-authors of R Edelstein

This figure shows the co-authorship network connecting the top 25 collaborators of R Edelstein. A scholar is included among the top collaborators of R Edelstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Edelstein. R Edelstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuhn, Jean‐Marc, T Billebaud, H Navratil, et al.. (1989). Prevention of the Transient Adverse Effects of a Gonadotropin-Releasing Hormone Analogue (Buserelin) in Metastatic Prostatic Carcinoma by Administration of an Antiandrogen (Nilutamide). New England Journal of Medicine. 321(7). 413–418. 159 indexed citations
2.
Bonde, Jesper, Rasmus Holmboe Dahl, R Edelstein, et al.. (1986). The effect of RU 41.740, an immune modulating compound, in the prevention of acute exacerbations in patients with chronic bronchitis.. PubMed. 69(4). 235–41. 16 indexed citations
3.
Edelstein, R, et al.. (1984). HISTAMINE RELEASE BY BARBITURATES IN HUMAN MAST CELLS. Anesthesiology. 61(3). A352–A352. 4 indexed citations
4.
Smets, P., et al.. (1982). Synergistic effect between an immunomodulating compound (biostim) and antibiotic treatment (ampicillin) in lethal staphylococcal infection in mice. International Journal of Immunopharmacology. 4(4). 369–369. 3 indexed citations
5.
Israël, Lucien, et al.. (1982). In vivo nonspecific macrophage chemotaxis in cancer patients and its correlation with extent of disease, regional lymph node status, and disease-free survival.. PubMed. 42(6). 2489–94. 14 indexed citations
6.
Edelstein, R, et al.. (1982). Immunosuppressive effect of acute-phase reactant proteins in vitro and its relevance to cancer. Cancer Immunology Immunotherapy. 13(1). 38–43. 49 indexed citations
7.
Israel, Liron L., et al.. (1981). [Immunosuppressive effects of acute phase reactant proteins. Physiopathological role in cancer patients (author's transl)].. PubMed. 132(1). 26–9. 4 indexed citations
8.
Golub, Sidney H., et al.. (1981). Lymphoid Cells Infiltrating Human Pulmonary Tumors: Effect of Intralesional BCG Injection<xref ref-type="fn" rid="FN2">2</xref><xref ref-type="fn" rid="FN3">3</xref>. JNCI Journal of the National Cancer Institute. 67(5). 997–1003. 24 indexed citations
9.
Israël, Lucien, et al.. (1980). Influence of Tumor Burden, Tumor Removal, Immune Stimulation, Plasmapheresis on Monocyte Mobilization in Cancer Patients. Advances in experimental medicine and biology. 121B. 411–423. 6 indexed citations
10.
Israël, Lucien, et al.. (1978). Immunological and plasma protein changes in cancer patients following a single plasmapheresis.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 28(5). 292–7. 7 indexed citations
11.
Israël, Lucien & R Edelstein. (1978). In vivo and in vitro studies on nonspecific blocking factors of host origin in cancer patients. Role of plasma exchange as an immunotherapeutic modality.. PubMed. 14(1). 105–30. 20 indexed citations
12.
Israël, Lucien, et al.. (1977). Immunochemotherapy in 34 cases of oat cell carcinoma of the lung with 19 complete responses.. PubMed. 61(3). 343–7. 20 indexed citations
13.
14.
Israël, Lucien, et al.. (1975). Brief Communication: Daily Intravenous Infusions of Corynebacterium parvum in Twenty Patients With Disseminated Cancer: A Preliminary Report of Clinical and Biologic Findings. JNCI Journal of the National Cancer Institute. 55(1). 29–33. 55 indexed citations
15.
Israël, Lucien & R Edelstein. (1975). IMMUNOLOGICAL CONTROL OF CANCER. The Lancet. 305(7913). 979–980. 8 indexed citations
16.
Israël, Lucien, et al.. (1975). Effect of intranodular B.C.G. in 22 melanoma patients.. PubMed. 17(5-6). 187–8. 9 indexed citations
17.
Edelstein, R, et al.. (1969). So-called left atrial rhythm.. PubMed. 69(9). 1215–8. 1 indexed citations
18.
Edelstein, R. (1965). Supravalvular aortotomy infection. Caused by Listeria monocytogenes, masquerading as subacute bacterial endocarditis. Archives of Internal Medicine. 116(6). 937–939. 17 indexed citations
19.
Hardaway, Robert M., et al.. (1956). Pathologic study of intravascular coagulation following incompatible blood transfusion in dogs. The American Journal of Surgery. 91(1). 24–31. 47 indexed citations
20.
McKay, Donald G., et al.. (1955). Alterations in blood coagulation mechanism after incompatible blood transfusion. The American Journal of Surgery. 89(3). 583–592. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Jansen Breakdown of academic impact, for papers by Masaki Kawakami Breakdown of academic impact, for papers by J E Parrillo Breakdown of academic impact, for papers by J Hugues Breakdown of academic impact, for papers by Jeanne A. Lumadue Breakdown of academic impact, for papers by S. Segal Breakdown of academic impact, for papers by Øyvind Bruserud Breakdown of academic impact, for papers by E. Dybkjær Breakdown of academic impact, for papers by Bradley P. Sullivan Breakdown of academic impact, for papers by M Kopeć
Rankless by CCL
2026